PAVmed Price Earnings Ratio from 2010 to 2025

PAVMZ Stock  USD 0.01  0.0008  13.11%   
PAVmed Series Price Earnings Ratio yearly trend continues to be fairly stable with very little volatility. Price Earnings Ratio is likely to outpace its year average in 2025. During the period from 2010 to 2025, PAVmed Series Price Earnings Ratio regression line of annual values had r-squared of  0.74 and arithmetic mean of (42.52). View All Fundamentals
 
Price Earnings Ratio  
First Reported
2010-12-31
Previous Quarter
0.00018987
Current Value
0.000199
Quarterly Volatility
56.48257862
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Selling General Administrative of 25.8 B, Income Before Tax of 29.8 B or Net Income of 33.6 B, as well as many indicators such as Price To Sales Ratio of 0.0019, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 2.08. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.
  
Check out the analysis of PAVmed Series Correlation against competitors.

Latest PAVmed Series' Price Earnings Ratio Growth Pattern

Below is the plot of the Price Earnings Ratio of PAVmed Series Z over the last few years. It is PAVmed Series' Price Earnings Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.
Price Earnings Ratio10 Years Trend
Slightly volatile
   Price Earnings Ratio   
       Timeline  

PAVmed Price Earnings Ratio Regression Statistics

Arithmetic Mean(42.52)
Geometric Mean2.77
Coefficient Of Variation(132.83)
Mean Deviation50.02
Median(3.24)
Standard Deviation56.48
Sample Variance3,190
Range123
R-Value0.86
Mean Square Error903.06
R-Squared0.74
Significance0.000021
Slope10.18
Total Sum of Squares47,854

PAVmed Price Earnings Ratio History

2025 1.99E-4
2024 1.9E-4
2023 -0.46
2022 -0.42
2021 -3.79
2020 -2.93
2019 -2.27

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Price Earnings Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.